West Pharmaceutical Services INC (WST) — 8-K Filings

All 8-K filings from West Pharmaceutical Services INC. Browse 13 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (13)

8-K Filing — Apr 23, 2026
West Pharmaceutical Services Reports Director & Officer Changes — Sep 11, 2025 Risk: medium
On September 11, 2025, West Pharmaceutical Services, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangement
West Pharmaceutical Services Files 8-K on Officer/Director Changes — Jul 21, 2025 Risk: low
On July 21, 2025, WEST PHARMACEUTICAL SERVICES, INC. filed an 8-K report. The filing pertains to the departure of directors or certain officers, the election of
West Pharmaceutical Services Holds Annual Stockholder Meeting — May 8, 2025 Risk: low
On May 6, 2025, West Pharmaceutical Services, Inc. filed an 8-K report to announce the results of its annual meeting of stockholders held on May 6, 2025. The co
West Pharmaceutical Services Announces Leadership Changes — Apr 14, 2025 Risk: medium
On April 9, 2025, West Pharmaceutical Services, Inc. reported a departure of a director, Mr. David L. Johnson, who resigned from the Board of Directors. The com
West Pharmaceutical Services Reports Director & Officer Changes — Mar 11, 2025 Risk: medium
On March 7, 2025, West Pharmaceutical Services, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing incl
West Pharmaceutical Services Files 8-K — Feb 13, 2025 Risk: low
On February 13, 2025, WEST PHARMACEUTICAL SERVICES, INC. filed an 8-K report. The filing primarily concerns the company's results of operations and financial co
West Pharmaceutical Services Files 8-K — Dec 13, 2024 Risk: low
On December 9, 2024, West Pharmaceutical Services, Inc. filed an 8-K report. The filing primarily concerns the submission of financial statements and exhibits.
West Pharmaceutical Services Elects New Directors — Dec 11, 2024 Risk: low
On December 9, 2024, West Pharmaceutical Services, Inc. announced the election of two new directors, Dr. Steven A. Muchmore and Ms. Karen L. King, to its Board
West Pharmaceutical Services Reports Director and Officer Changes — Oct 7, 2024 Risk: medium
On October 1, 2024, West Pharmaceutical Services, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements.
West Pharmaceutical Services Secures $1.5B Credit Facility — Jul 8, 2024 Risk: low
On July 2, 2024, West Pharmaceutical Services, Inc. entered into a Material Definitive Agreement, specifically a Credit Agreement, with JPMorgan Chase Bank, N.A
West Pharmaceutical Services CFO Departs; Director Changes — Apr 26, 2024 Risk: medium
On April 23, 2024, West Pharmaceutical Services, Inc. filed an 8-K report detailing several key events. The company announced the departure of its Chief Financi
West Pharma Files 8-K for Financial Results and Disclosure — Feb 15, 2024 Risk: medium
WEST PHARMACEUTICAL SERVICES, INC. filed an 8-K on February 15, 2024, to report on its Results of Operations and Financial Condition. The filing also included a

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX